Free Trial
NASDAQ:PMCB

Nuvilex (PMCB) Stock Price, News & Analysis

Nuvilex logo
$0.97 -0.04 (-3.99%)
Closing price 04:00 PM Eastern
Extended Trading
$0.97 0.00 (0.00%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nuvilex Stock (NASDAQ:PMCB)

Key Stats

Today's Range
$0.95
$1.03
50-Day Range
$0.83
$1.14
52-Week Range
$0.80
$2.42
Volume
24,751 shs
Average Volume
28,618 shs
Market Capitalization
$6.60 million
P/E Ratio
0.37
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuvilex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

PMCB MarketRank™: 

Nuvilex scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nuvilex.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuvilex is 0.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuvilex is 0.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.83.

  • Price to Book Value per Share Ratio

    Nuvilex has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Nuvilex's valuation and earnings.
  • Percentage of Shares Shorted

    0.18% of the float of Nuvilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvilex has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nuvilex has recently increased by 8.65%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nuvilex does not currently pay a dividend.

  • Dividend Growth

    Nuvilex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.18% of the float of Nuvilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvilex has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nuvilex has recently increased by 8.65%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nuvilex has a news sentiment score of 1.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nuvilex this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for PMCB on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Nuvilex to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuvilex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.20% of the stock of Nuvilex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 34.24% of the stock of Nuvilex is held by institutions.

  • Read more about Nuvilex's insider trading history.
Receive PMCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvilex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PMCB Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
MyMD Pharmaceuticals Secures Strategic Investments
PharmaCyte Biotech Inc PMCB
See More Headlines

PMCB Stock Analysis - Frequently Asked Questions

Nuvilex's stock was trading at $1.57 at the beginning of 2025. Since then, PMCB shares have decreased by 37.8% and is now trading at $0.9760.

Nuvilex Inc. (NASDAQ:PMCB) posted its earnings results on Friday, August, 8th. The company reported ($0.25) EPS for the quarter.

Shares of PMCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuvilex investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), ASML (ASML), GE Aerospace (GE), Oracle (ORCL) and Nokia (NOK).

Company Calendar

Last Earnings
8/08/2025
Today
8/27/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PMCB
CIK
1157075
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$2.59
Trailing P/E Ratio
0.38
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$30.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
4.60%
Return on Assets
3.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.68
Quick Ratio
7.68

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.56 per share
Price / Book
0.13

Miscellaneous

Outstanding Shares
6,800,000
Free Float
6,103,000
Market Cap
$6.64 million
Optionable
Optionable
Beta
-0.29
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:PMCB) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners